Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Non-cash Items (2018 - 2026)

Cogent Biosciences' Non-cash Items history spans 9 years, with the latest figure at $44.6 million for Q1 2026.

  • Quarterly Non-cash Items rose 437.35% to $44.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $44.6 million through Mar 2026, up 437.35% year-over-year, with the annual reading at $16.8 million for FY2025, 8291.53% up from the prior year.
  • Non-cash Items came in at $44.6 million for Q1 2026, up from $16.8 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $55.6 million in Q1 2024 to a low of $200000.0 in Q4 2024.
  • The 5-year median for Non-cash Items is $12.4 million (2024), against an average of $25.0 million.
  • Year-over-year, Non-cash Items plummeted 99.45% in 2023 and then surged 18433.33% in 2024.
  • Cogent Biosciences' Non-cash Items stood at $47.5 million in 2022, then tumbled by 82.22% to $8.4 million in 2023, then tumbled by 97.63% to $200000.0 in 2024, then soared by 8291.53% to $16.8 million in 2025, then soared by 165.74% to $44.6 million in 2026.
  • Per Business Quant, the three most recent readings for COGT's Non-cash Items are $44.6 million (Q1 2026), $16.8 million (Q4 2025), and $3.3 million (Q3 2025).